Carlsbad, CA - September 14, 2006 - Micromet, Inc. (NASDAQ: MITI), a biopharmaceutical company focusing on the development of novel, proprietary antibody-based products for cancer, inflammatory and autoimmune diseases, announced today that Christian Itin, President & Chief Executive Officer of Micromet, Inc., will give a corporate presentation to the investment community at the UBS Global Life Sciences Conference on Wednesday, September 27, 2006 at 08:00 a.m. Eastern time (02:00 p.m. Central European Time) at the Grand Hyatt Hotel in New York City.
